| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |